Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
U.S. Supreme Court rules against Amgen bid to revive cholesterol drug patents
10:13am, Thursday, 18'th May 2023
The U.S. Supreme Court on Thursday ruled against Amgen Inc in its bid to revive patents on its cholesterol-lowering drug Repatha over a legal challenge by French rival Sanofi SA.
FTC effort to stop Amgen's Horizon takeover faces uphill fight
06:04am, Thursday, 18'th May 2023
The Federal Trade Commission (FTC) faces an uphill battle in its fight against Amgen Inc's $27.8 billion acquisition of Horizon Therapeutics with an untested argument before a Trump-appointed judge, t
FTC Challenges Amgen's (AMGN) $28B Acquisition of Horizon
03:52pm, Wednesday, 17'th May 2023
Per the FTC, Amgen's (AMGN) acquisition of Horizon (HZNP) would entrench the monopoly positions for the latter's medications for thyroid eye disease and chronic refractory gout.
Dow Jones Today: Index Slumps on Retail Sales
10:31am, Wednesday, 17'th May 2023
The Dow Jones Industrial Average fell 1%, or 336 points, on a day of disappointing earnings and macroeconomic reports. Nike lost the most, while Microsoft led a small pack of gainers.
FTC Seeks to Block Amgen's Acquisition of Horizon Therapeutics: What's Next for Both Stocks?
05:13am, Wednesday, 17'th May 2023
The FTC wants to block Amgen's acquisition of Horizon even though the two companies' products don't overlap. The agency thinks that Amgen could try to bundle Horizon's products in a way that discourag
Is This Dow Jones Stock a Buy for Income Investors?
05:06am, Wednesday, 17'th May 2023
Amgen's revenue and profits dipped in the first quarter. The company's market-beating dividend is poised to rise moving forward.
Home Depot cuts outlook, FTC blocks Amgen deal, Comcast's may sell Hulu stake to Disney
05:41pm, Tuesday, 16'th May 2023
Yahoo Finance's Akiko Fujita and Diane King Hall break down Tuesday's biggest stories, including Home Depot earnings report, the FTC suing to block Amgen's deal to buy Horizon Therapeutics, and Comcas
FTC May Reportedly Block Amgen's (AMGN) $28B Horizon Buyout
04:43pm, Tuesday, 16'th May 2023
Unconfirmed reports suggest that the FTC may challenge the $28-billion buyout of Horizon Therapeutics (HZNP) by Amgen.
FTC sues to block Amgen's $27.8 billion deal to acquire Horizon Therapeutics
04:09pm, Tuesday, 16'th May 2023
Yahoo Finance healthcare reporter Anjalee Khemlani joins the Live Show to discuss details surrounding the FTC suing biopharmaceutical giant Amgen Inc and its plan to block Amgen's $27.8 billion deal t
Jefferies' Michael Yee expects Amgen's Horizon Therapeutics deal will go through despite FTC block
02:51pm, Tuesday, 16'th May 2023
Michael Yee, Jefferies managing director, joins 'Power Lunch' to discuss the FTC's move to block Amgen's $27.8 billion deal for Horizon Therapeutics.
FTC Suing To Stop Amgen's $27.8 Billion Purchase Of Horizon Therapeutics
12:21pm, Tuesday, 16'th May 2023
The FTC is attempting to stop the sale out of fears it will give the company too much power over rare disease treatments.
FTC to challenge Amgen's $28 billion deal with Horizon Therapeutics: Report
12:08pm, Tuesday, 16'th May 2023
Yahoo Finance Live anchors Julie Hyman and Brad Smith discuss the sharp decline of Horizon Therapeutics shares after a report surfaced that the FTC is planning to sue to block Amgen's $28 billion purc
FTC's Amgen Activism Will Spare These Biotechs
11:47am, Tuesday, 16'th May 2023
Federal Trade Commission action to block Amgen-Horizon deal threatens the thesis driving biotech stocks higher.
FTC Poised to Block Amgen's $27.8 Billion Deal for Horizon Therapeutics
10:21am, Tuesday, 16'th May 2023
The FTC is preparing to seek an injunction in federal court that would prevent the deal from closing.
FTC to challenge Amgen's $27.8B acquisition of Horizon Therapeutics: report
10:02am, Tuesday, 16'th May 2023
Shares of Horizon Therapeutics tumbled on Tuesday following a report that the Federal Trade Commission (FTC) is preparing to block its $27.8 billion sale to Amgen. Per a Bloomberg report citing an un
